Cancer Archives

News and Trends 11 Oct 2022

TILT Biotherapeutics doses first U.S. patient in ovarian cancer immunotherapy trial

TILT Biotherapeutics says the first U.S. patient has been dosed in its ovarian cancer trial using its oncolytic adenovirus, TILT-123. The company said TILT-123 has the potential to be first-in-class for this indication. The open-label, phase I, dose-escalation, multicenter, and multinational, clinical trial of TILT-123 in combination with MSD’s (a tradename of Merck & Co., […]

October 11, 2022 - 2 minutesmins - By Jim Cornall

Anastasiia Slynko biotech investment 744x368 1

In Depth 11 Oct 2022

The biggest private biotech investments in September 2022

The companies Acelyrin, InnovaFeed and Arsenal Biosciences bagged the biggest biotech investments in September 2022, with insect protein and cell therapies attracting big funding rounds. Autumn is in full swing in the Northern Hemisphere. After a breather in August 2022, September saw the return of big fundraising activity for biotech companies. We’ve gathered the biggest […]

October 11, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 10 Oct 2022

JW Therapeutics receives approval for relapsed or refractory follicular lymphoma drug

China’s National Medical Products Administration (NMPA) has approved the supplemental new drug application (sNDA) for JW Therapeutics’ anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product relmacabtagene autoleucel injection. Also known as relma-cel, the product has the trade name Carteyva. It is used for the treatment of adult patients with follicular lymphoma that is […]

October 10, 2022 - 3 minutesmins - By Jim Cornall

More News! 10 Oct 2022

RadioMedix announces a $40 million series A financing for targeted alpha therapy platform

A company committed to advancing treatments for rare and aggressive cancers has received a series A funding of $40 million. Clinical stage biotech, RadioMedix, Inc. announced the agreement with an entity related to Portland Investment Counsel Inc. (Portland), on Friday (October 7). RadioMedix is committed to the advancement of a targeted alpha therapy (TAT) pipeline […]

October 10, 2022 - 3 minutesmins - By Liza Laws

News and Trends 10 Oct 2022

Biocartis starts European commercialization of liver cancer test

Biocartis Group NV has started the commercialization in Europe of the HepatoPredict test as a CE-IVD marked manual kit. The test, developed by Portuguese biotech company Ophiomics, is a prognostic diagnostic test that supports the decision of liver transplantation in patients with hepatocellular carcinoma (HCC). Herman Verrelst, chief executive officer of Biocartis, said: “We are […]

October 10, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 10 Oct 2022

Saudi university study could pave way for new cancer drugs

Precise details of how a master regulator of gene expression binds its activating partner could open new avenues for cancer drug development. The findings were made at the King Abdullah University Of Science And Technology in Saudi Arabia. They reveal how the activating partner, a small cellular metabolite and signaling molecule called PI5P, interacts simultaneously […]

October 10, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Oct 2022

AI model study may lead to identifying skin cancer from blood test

Researchers have developed an artificial intelligence (AI) model that predicts which skin cancer patients will benefit from a treatment that activates the immune defense system. The scientists are from the University of Helsinki, HUS Comprehensive Cancer Center, Aalto University and Stanford University. In practice, the AI model makes it possible to diagnose skin cancer with […]

October 7, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Oct 2022

Scientists at IRB Barcelona and PCCB create study model for Ewing sarcoma

Ewing sarcoma is the second most frequent bone tumor in children, adolescents, and young adults. There is no specific treatment for this disease and current management is still limited to surgery, radiotherapy, and chemotherapy. The long-term survival of patients with metastatic or relapsed Ewing sarcoma is very low. Ewing sarcoma is caused by a single […]

October 7, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Oct 2022

New approaches beckon for small cell lung cancer treatment

Small cell lung cancer (SCLC) is a particularly aggressive tumor that has so far been treated with standardized measures. However, a study led by MedUni Vienna in Austria has shown for the first time that different SCLC subtypes have specific molecular characteristics, which is why those affected respond in different ways to cancer treatment. This […]

October 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Oct 2022

FDA fast tracks Immutep non-small cell lung cancer candidate

Immutep Limited says the United States Food and Drug Administration (FDA) has granted fast track designation to eftilagimod alpha (efti or IMP321) in combination with pembrolizumab for the treatment of first line non-small cell lung cancer (NSCLC). Efti is the company’s first-in-class soluble LAG-3 clinical stage candidate, which activates antigen presenting cells (APC) to engage […]

October 5, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Oct 2022

OncoSec slashing staff numbers to prioritize pipeline

OncoSec Medical Incorporated is restructuring to prioritize development of its lead clinical candidate TAVO (TAVO-EP). TAVO is a plasmid encoding interleukin 12 (IL-12) delivered by intratumoral electroporation. Oncosec is reducing its staff by approximately 45% and prioritizing clinical pipeline activities to reduce operating expenses. The company and remaining employees will focus clinical activities in melanoma […]

October 5, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 4 Oct 2022

Discovery of how metastatic cancer cells infiltrate the liver may lead to new drugs

Approximately 90% of cancer-related deaths are due to metastasis when cancer spreads and forms new tumors. The liver is considered the most vulnerable organ to metastatic cancer: the five-year survival rate after surgery to remove liver metastases is as low as 30 to 50%, so developing treatments to prevent liver metastasis is urgently needed. A […]

October 4, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer

TILT Biotherapeutics doses first U.S. patient in ovarian cancer immunotherapy trial

The biggest private biotech investments in September 2022

JW Therapeutics receives approval for relapsed or refractory follicular lymphoma drug

RadioMedix announces a $40 million series A financing for targeted alpha therapy platform

Biocartis starts European commercialization of liver cancer test

Saudi university study could pave way for new cancer drugs

AI model study may lead to identifying skin cancer from blood test

Scientists at IRB Barcelona and PCCB create study model for Ewing sarcoma

New approaches beckon for small cell lung cancer treatment

FDA fast tracks Immutep non-small cell lung cancer candidate

OncoSec slashing staff numbers to prioritize pipeline

Discovery of how metastatic cancer cells infiltrate the liver may lead to new drugs

Subscribe to our newsletter to get the latest biotech news!

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!